Спец. д.м.н. Hakan Taban

A. Статьи, принятые к публикации в международных рецензируемых журналах (In Press)

• Renal transplantation in recipients older than 65 years: Retrospective analysis of the results of a 3-year experience. S. Tekin, H. A. Yavuz, Y. Yüksel, İ. Ateş, L. Yücetin, L. Dösemeci, M. Tuncer, A. Demirbaş. Transplantation Proceedings, 2015. (In press)

• Kidney transplantation from elderly donor. S. Tekin, H. A. Yavuz, Y. Yüksel, L. Yücetin, İ. Ateş, M. Tuncer, A. Demirbaş. Transplantation Proceedings, 2015. (In press)

• Donors with hepatitis B surface antigen positivity. H. A. Yavuz, S. Tekin, Y. Yüksel, İ. Ateş, L. Yücetin, M. Demir, B. Uygun, M. Tuncer, A. Demirbaş. Transplantation Proceedings, 2015. (In press)

B. Статьи, опубликованные в международных научных журналах

• Influence of inflammation on the relation between markers of iron deficiency in renal replacement therapy. Transplantation Proceedings, 2004.

• Influence of tacrolimus and mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients. Transplantation Proceedings, 2004.

• Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients. Transplantation Proceedings, 2004.

• Cigarette smoking in renal transplant recipients. Transplantation Proceedings, 2004.

• Serum cystatin C as an index of renal function in renal transplant patients. Transplantation Proceedings, 2004.

• Seroprevalence of antibodies to Legionella pneumophila in hemodialysis patients. Transplantation Proceedings, 2004.

• Phosphate kinetics during different dialysis modalities. Blood Purification, 2005.

• Uremic toxins: A new focus on an old subject. Seminars in Dialysis, 2005.

• Effect of renal transplantation on endothelial function in hemodialysis patients. Nephrology Dialysis Transplantation, 2006.

C. Международные тезисы, опубликованные в сборниках материалов

• Monitoring of human cytomegalovirus infection by antigenemia assay in seropositive renal transplant recipients. International Journal of Infectious Diseases, 2002 (Supplement).

• Influence of tacrolimus and mycophenolate mofetil regimens on acute rejection rate and side effect profiles. Joint Meeting of the Turkish Transplantation Society and Eurotransplant, 2003.

• Cigarette smoking and alcohol intake in renal transplant recipients. Joint Meeting of the Turkish Transplantation Society and Eurotransplant, 2003.

• Renal replacement therapy in acute renal failure: Which index is best for adequacy? World Congress of Nephrology, 2005.

D. Статьи, опубликованные в национальных научных журналах и доклады на национальных конференциях

• Hemostatic disorders in thyroid diseases. Endokrinolojide Yönelişler, 2003.

• Hypertension mechanisms in acute and rapidly progressive renal failure. Türkiye Klinikleri – Nephrology, 2005.

• Combination of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in kidney diseases. Turkish Journal of Nephrology, 2004.

E. Прочие научные публикации и переводы книг

• Reviewer for Critical Care journal (Bellomo et al.).

• Cecil Textbook of Medicine, Turkish edition, Chapters on Acid–Base Disorders, Phosphate Deficiency, Magnesium Metabolism, Acute and Chronic Renal Failure – Translation by Dr. Asuman Yavuz.

• Pathophysiology of Diseases, Turkish edition – Chapters on endocrine pancreas and adrenal cortex disorders.

• Basic Geriatrics (Temel Geriatri) – Chapters on acute and chronic renal failure.

Награды

• 2020 – 10th International Gastrointestinal Cancers Virtual Conference (2–6 December). A rare metastasis case: BRAF V600 Mutation Positive Gastrointestinal Stromal Tumor with Breast Metastasis — Best Poster Award.

• 2022 – 20th Western Europe Masterclass in Medical Oncology, Spain — First Place Award in Assessment and Evaluation Examination.

• 2022 – Turkish Society of Medical Oncology — Medical Oncology Board Certification, Third Place Award.

• 2023 – ESMO Examination Certificate — Listed among Top Scoring Candidates.

Исследовательская деятельность и публикации

• 2020 – 7th International Multidisciplinary Good Medical Research Congress and Good Oncology Research Conference (Virtual). Enzalutamide Single Center Experience in Metastatic Castration-Resistant Prostate Cancer — Oral Presentation.

• 2021 – 11th International Gastrointestinal Cancer Conference, Istanbul. Evaluation of the impact of preoperative sarcopenia on treatment results and survival in patients with pancreatic cancer — Oral Presentation.

• 2021 – 11th International Gastrointestinal Cancer Conference, Istanbul. Evaluation of gastrointestinal cancer patients radiologically diagnosed with sinusoidal obstruction syndrome: Single-Center Experience — Oral Presentation.

• Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. Aktas B.Y., Taban H., Aksoy S. N Engl J Med. 2019;380(10):985–986. doi:10.1056/NEJMc1900150.

• Defining the Optimal Regimen for Stage III Colon Cancer: Concerns with Study Design. Guven D.C., Guner G., Aktas B.Y., Aktepe O.H., Taban H., Arik Z. Clin Colorectal Cancer. 2020;19(3):e71–e72.

• Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitors. Guven D.C. et al. Support Care Cancer. 2020.

• The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer. Yasar H.A. et al. J Oncol Pharm Pract. 2020;26(5):1110–1116.

• Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma. Hizal M. et al. J Oncol Pharm Pract. 2020;26(7):1583–1589.

• Development of de novo psoriasis during nivolumab therapy in a patient with small cell lung cancer. Guven D.C. et al. J Oncol Pharm Pract. 2020;26(1):256–258.

• PILE: a candidate prognostic score in cancer patients treated with immunotherapy. Guven D.C. et al. Clin Transl Oncol. 2021;23(8):1630–1636.

• Lower prognostic nutritional index is associated with poorer survival in patients receiving immune checkpoint inhibitors. Guven D.C. et al. Biomark Med. 2021;15(13):1123–1130.

• Impact of albumin to globulin ratio on survival outcomes of patients with metastatic renal cell carcinoma. Aktepe O.H. et al. Turk J Urol. 2021;47(2):113–119.

• Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database. Yekedüz E. et al. Future Oncol. 2021;17(35):4861–4869.

• Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy. Guven D.C. et al. Support Care Cancer. 2021;29(9):5417–5423.

• Adjuvant Capecitabine In Triple Negative Breast Cancer: The Earlier, The Better? Guven D.C., Taban H., Dizdar O. J Oncol Pharm Pract. 2022;28(1):203–204.

• Adjuvant treatment with paclitaxel plus trastuzumab for node-negative breast cancer: real-life experience. Diker O. et al. Future Oncol. 2022;18(3):323–331.

• Crizotinib Efficacy After Progression With Entrectinib in ROS1-Positive Lung Cancer: A Case Report. Taban H., Guven D.C., Kılıçkap S. Cureus. 2022;14(8):e27828.

• Blood Based Biomarkers as Predictive Factors for Hyperprogressive Disease. Yildirim H.C. et al. J Clin Med. 2022;11(17):5171.

• Prognosis of Liposarcoma Patients in Modern ERA: Single-Center Experience. Demir M. et al. South Asian J Cancer. 2022;11(4):287–292.

• The Prognostic Significance of KIAA1522 Expression in Non-Small-Cell Lung Cancer Patients. Özdede M. et al. Cureus. 2023;15(8):e44016.

• Prognostic and predictive value of tumoral DNA damage repair protein expression in patients with resected pancreatic cancer. Ceylan F. et al. Clin Res Hepatol Gastroenterol. 2023;47(3):102091.

• Prognostic and predictive value of tumor infiltrating lymphocytes in combination with systemic inflammatory markers in colon cancer. Efil S.C. et al. Clin Res Hepatol Gastroenterol. 2023;47(7):10217